Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective

Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective

Vaccine marketing authorization holders (MAHs) are responsible for the conduction of global vaccine pharmacovigilance on their vaccine products. A safety signal is detected when a new adverse event (AE) or aspect of an AE occurs after exposure to the vaccine and warrants further investigation to det...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Maddalena Lino, Susan Mather, Marianna Trani, Yan Chen, Patrick Caubel, Barbara De Bernardi
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
signal detection
signal evaluation
COVID-19 vaccine
efficacy
safety
adverse event following immunization
Online Access:https://www.mdpi.com/2076-393X/13/5/481
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/5/481

Similar Items